Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer.

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer.

Item
http://www.wikidata.org/entity/Q33994406
The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targetsTargeted Therapy in Biliary Tract CancersLong non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer.New Horizons for Precision Medicine in Biliary Tract Cancers.Immunotherapeutic Approaches to Biliary Cancer.The NmrA-like family domain containing 1 pseudogene Loc344887 is amplified in gallbladder cancer and promotes epithelial-mesenchymal transition.Novel investigational therapies for treating biliary tract carcinoma.Current biologics for treatment of biliary tract cancers.Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer.Incidence, risk and prognostic role of anti-epidermal growth factor receptor-induced skin rash in biliary cancer: a meta-analysis.Phase I trial of S-1 every other day in combination with gemcitabine/cisplatin for inoperable biliary tract cancer.New molecular and immunotherapeutic approaches in biliary cancer.EGFR Target Therapy Combined with Gemox for Advanced Biliary Tract Cancers: a Meta-analysis based on RCTs.Tumor-infiltrating mast cells predict prognosis and gemcitabine-based adjuvant chemotherapeutic benefit in biliary tract cancer patients.
P2860

Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancer.

Item
http://www.wikidata.org/entity/Q33994406
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Phase II study of gemcitabine, ...... tract and gallbladder cancer.
@ast
Phase II study of gemcitabine, ...... tract and gallbladder cancer.
@en
type
label
Phase II study of gemcitabine, ...... tract and gallbladder cancer.
@ast
Phase II study of gemcitabine, ...... tract and gallbladder cancer.
@en
prefLabel
Phase II study of gemcitabine, ...... tract and gallbladder cancer.
@ast
Phase II study of gemcitabine, ...... tract and gallbladder cancer.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Phase II study of gemcitabine, ...... y tract and gallbladder cancer
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P6179
P698
P932